如何向SCI生物医学期刊投稿.pptVIP

How to Choose a Journal Scope Prestige Publication lag Acceptance rate Audience Open policy Payments 2010 Cited Information J Title TC IF EigenfactorTM Score Article InfluenceTM Score NEJM 227 674 53.484 0.69167 21.366 Nature 511 145 36.101 1.74466 19.334 Lancet 155 734 33.633 0.38031 12.720 Cell 167 587 32.401 0.70472 20.639 Science 469 704 31.364 1.46485 16.859 JAMA 117 495 30.011 0.30973 12.443 Editorial Policies Duplicate publication or submission Copyright transfer Conflict of interest statement Clinical trial registration 1. Duplicate Submission Acceptable Secondary Publication： Certain types of articles, such as guidelines In the same or another language, especially in other countries, is justifiable and can be beneficial provided that the following conditions are met 2. Copyright Copyright transfer agreement Copyright permissions Works made for hire 3. Conflict of interest An author (or the author’s institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). Statement: disclosing all financial and personal relationships that might bias authors‘ work 4. Clinical Trial Registration The ICMJE member journals will require, as a condition of consideration for publication in their journals, registration in a public trials registry. Medical interventions ClinicalTrial America ISRCTN Englang ANZCTR Australian, New Zealand UMIN Japan DRKS German ChiCTR Chinese TRIAL Dutch NIPH Japanese CRIS Korean IRCT Iranian ReBEC Portuguese RPCEC Spanish International Clinical Trials Registry Platform (ICTRP) Manuscript Submi